98 related articles for article (PubMed ID: 2741652)
21. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
[TBL] [Abstract][Full Text] [Related]
22. Effect of vinpocetine on red blood cell deformability in stroke patients.
Hayakawa M
Arzneimittelforschung; 1992 Apr; 42(4):425-7. PubMed ID: 1642666
[TBL] [Abstract][Full Text] [Related]
23. Hereditary high phosphatidylcholine hemolytic anemia: report of a new family and review of the literature.
Shojania AM; Godin DV; Frohlich J
Clin Invest Med; 1990 Dec; 13(6):313-21. PubMed ID: 1964113
[TBL] [Abstract][Full Text] [Related]
24. Phase I trial of vinzolidine.
Budman DR; Schulman P; Marks M; Vinciguerra V; Weiselberg L; Kreis W; Degnan TJ
Cancer Treat Rep; 1984; 68(7-8):979-82. PubMed ID: 6744350
[TBL] [Abstract][Full Text] [Related]
25. Recent trends in the treatment and prognosis of adult leukemia with characteristics of patients in Japan: transition during the fifteen years from 1971 to 1985.
Suzuki H; Ota K; Ohno R; Masaoka T; Shibata H; Kimura I; Amaki I; Miura Y; Uzuka Y; Kawato M
Jpn J Clin Oncol; 1989 Dec; 19(4):338-47. PubMed ID: 2607637
[TBL] [Abstract][Full Text] [Related]
26. [Congenital xerocytosis: apropos of 2 new cases].
Merino A; Vives Corrons JL; Berga L; Aguilar i Bascompte JL; Jou JM; González I; Cusó E
Sangre (Barc); 1987; 32(6):743-53. PubMed ID: 3438813
[No Abstract] [Full Text] [Related]
27. [Vinca-alkaloid slow infusion therapy in refractory idiopathic thrombocytopenic purpura].
Endoh N; Wong P; Wakita H; Nakamura H; Sugiura Y; Asai T; Itoh K; Yoshida S
Rinsho Ketsueki; 1987 Feb; 28(2):194-8. PubMed ID: 3573337
[No Abstract] [Full Text] [Related]
28. [A case of congenital stomatocytosis with decreased red cell sodium content, increased red cell sodium efflux and pulmonary embolism].
Murai K; Yasunari K; Yasuda M; Negoro N; Yoshikawa C; Tatsumi J; Tatsumi N; Sugihara T; Shimoda M; Hashimoto M
Rinsho Ketsueki; 1985 May; 26(5):789-94. PubMed ID: 2997502
[No Abstract] [Full Text] [Related]
29. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
[TBL] [Abstract][Full Text] [Related]
30. Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors.
Ono M; Tanaka N
In Vivo; 1997; 11(3):233-41. PubMed ID: 9239517
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of S12363, a novel vinca alkaloid drug in the treatment of advanced malignant melanoma. A phase II study.
Stanley AJ; Kaprielian R; Retsas S
Anticancer Res; 1993; 13(1):31-2. PubMed ID: 8476226
[TBL] [Abstract][Full Text] [Related]
32. Acute bronchospasm after a vinca alkaloid in patients previously treated with mitomycin.
Dyke RW
N Engl J Med; 1984 Feb; 310(6):389. PubMed ID: 6690968
[No Abstract] [Full Text] [Related]
33. Vindesine: a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumors.
Smith IE; Hedley DW; Powles TJ; McElwain TJ
Cancer Treat Rep; 1978 Oct; 62(10):1427-33. PubMed ID: 709548
[No Abstract] [Full Text] [Related]
34. Hemolytic anemia and susceptibility to hydrogen-peroxide hemolysis in children with vitamin E-deficiency and chronic liver disease.
Fernández-Zamorano A; Arnalich F; Codoceo R; Vigara MR; Valverde F; Jara P; Vázquez JJ
J Med; 1988; 19(5-6):317-34. PubMed ID: 3204329
[TBL] [Abstract][Full Text] [Related]
35. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
[TBL] [Abstract][Full Text] [Related]
36. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
Dorr RT; Alberts DS
J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
[TBL] [Abstract][Full Text] [Related]
37. [Red cell fragmentation and hemolysis in thrombotic thrombocytopenic purpura (TTP)].
Kizaki M; Ikeda Y
Nihon Rinsho; 1993 Jan; 51(1):117-21. PubMed ID: 8433503
[TBL] [Abstract][Full Text] [Related]
38. The use of vinca alkaloids in preparation for splenectomy of corticosteroid refractory chronic immune thrombocytopenic purpura patients.
Szczepanik AB; Sikorska A; Slomkowski M; Konopka L
Int J Lab Hematol; 2007 Oct; 29(5):347-51. PubMed ID: 17824915
[TBL] [Abstract][Full Text] [Related]
39. [Use of alpha-tocopherol in correction of red blood (erythron) system disorders in rats with acute nitrite intoxication].
Miasoedova EE; Nazarov SB
Eksp Klin Farmakol; 2003; 66(5):35-9. PubMed ID: 14650213
[TBL] [Abstract][Full Text] [Related]
40. Case report: hypothyroidism as a possible cause of an acquired reversible hemolytic anemia.
Nomura S; Eimoto T; Osawa G; Yawata Y; Horino M
Am J Med Sci; 1991 Jul; 302(1):23-7. PubMed ID: 2063883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
